Ophthalmology · New York, NY
NPI
1265548168
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
305 2nd Ave Ste 10
New York, NY, 10003
Phone (212) 505-9640
Groups this clinician bills Medicare through
Medicare paid, 2024
$401K
6,568 services
Medicare patients, 2024
672
Average age 75
Drug cost, 2024
$102K
6,176 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Navin C Mehta was code 99213 (office e&m - established), 1,701 times for 591 patients. In total Navin C Mehta billed 6,568 services in 24 codes, and Medicare paid $401K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,701 | 591 | $71.57 | $122K |
| 92550 Test - Miscellaneous | Office | 1,223 | 603 | $17.04 | $21K |
| 31231 Nasal/Sinus Endoscopy | Office | 1,112 | 550 | $152.03 | $169K |
| 92588 Test - Miscellaneous | Office | 1,086 | 570 | $25.92 | $28K |
| G0268 Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 845 | 479 | $24.23 | $20K |
| 92557 Vision, Hearing, and Speech Services | Office | 348 | 284 | $28.53 | $9,929 |
| 99203 Office E&M - New | Office | 146 | 146 | $84.44 | $12K |
| 31575 Other Organ Systems | Office | 27 | 24 | $106.43 | $2,874 |
By year: 2022 $474K for 6,624 services; 2023 $463K for 6,788 services; 2024 $401K for 6,568 services.
Medicare prescription drug claims, 2024
In 2024, the drug Navin C Mehta prescribed most often to Medicare patients was Ipratropium Bromide, with 1,365 prescriptions and refills. In total Navin C Mehta wrote 6,176 Medicare prescriptions that cost $102K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 1,365 | 1,689 | 619 | $24K |
| Neomycin-Polymyxin-Hydrocort Neomycin/Polymyxin B/Hydrocort | 600 | 625 | 482 | $23K |
| Azithromycin Generic | 470 | 470 | 350 | $1,495 |
| Levocetirizine Dihydrochloride Generic | 463 | 556 | 186 | $3,465 |
| Fluticasone Propionate Generic | 405 | 571 | 173 | $3,620 |
| Cefuroxime Cefuroxime Axetil | 286 | 286 | 249 | $2,327 |
| Azelastine Hcl Generic | 246 | 326 | 93 | $3,034 |
| Ciprofloxacin Hcl Generic | 226 | 226 | 182 | $1,014 |
| Meclizine Hcl Generic | 201 | 229 | 103 | $832 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 195 | 195 | 157 | $1,145 |
| Ofloxacin Generic | 163 | 177 | 104 | $11K |
| Montelukast Sodium Generic | 157 | 242 | 57 | $1,092 |
| Mupirocin Generic | 139 | 139 | 84 | $865 |
| Neomycin-Polymyxin-Hc Neomycin/Polymyxin B/Hydrocort | 123 | 128 | 106 | $4,682 |
| Levofloxacin Generic | 119 | 119 | 102 | $305 |
Brand drugs: - claims; generic drugs: 6,076 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Navin C Mehta were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.